Team identifies key regulator blocking immunotherapy, paving the way for a new lung cancer treatment
Immune checkpoint inhibitors, a class of immunotherapies that help immune cells attack cancer more effectively, have revolutionized cancer treatment. However, fewer than 20% of patients respond to ...
Touro University3h
Cutting-Edge Treatment for Lung Cancer
Researchers from Touro University and Lovelace Biomedical are Developing an Innovative Treatment for Lung Cancer ...
Esther Rantzen shares heartbreaking 'extremely limited' lung cancer health update
Dame Esther Rantzen has said it would be “lovely” to meet her late husband Desmond Wilcox again in heaven, as she confirmed that her life-extending wonder drug has stopped working. The That’s Life ...
A gentle approach offers new hope for inflammatory lung diseases
Pulmonary sarcoidosis is a lung disease characterized by granulomas—tiny clumps of immune cells that form in response to ...
Clinical Trials Arena on MSN11h
FDA clears CureVac’s IND application for Phase I lung cancer trial
The US Food and Drug Administration (FDA) has granted clearance to CureVac's investigational new drug application (IND) for ...